Over the last 40 years, Glenmark has built the resources and talent to work on solving serious medical problems, all while doing the right thing for patients, people and communities. We are leveraging our industry expertise and success to fuel extensive research to expand development in specialty branded products and innovative products that are intended to have a major impact on how people live.
Glenmark’s R&D is dedicated to addressing unmet medical needs in inflammation disorders, especially in respiratory and dermatology therapies and also oncology. Our focus on these therapy areas is based on their significant size, rapid rates of growth, and our cumulative experience and track record in brand-building and patient-focused innovation in these areas in emerging markets. We also see a vast unmet need across these therapy areas for better, more economical and/or more convenient therapies.